Dynamic recurrence risk and adjuvant chemotherapy benefit prediction by ctDNA in resected NSCLC
2021 · Nature Communications · 268 citations
https://doi.org/10.1038/s41467-021-27022-z
Y
Yang Xu
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
343
Papers
8.4K
Citations
51
h-index
135
i10-index
Yang Xu is an academic researcher from University of South China. The author has contributed to research in topics: Mitochondrial Function and Pathology & Lung Cancer Treatments and Mutations & Cancer Genomics and Diagnostics. The author has an h-index of 51, co-authored 292 publications.
ORCID: 0000-0003-1670-6131Papers by this author
worksA metabolic stress-inducible miR-34a-HNF4α pathway regulates lipid and lipoprotein metabolism
2015 · Nature Communications · 267 citations
https://doi.org/10.1038/ncomms8466
The genomic origins of the Bronze Age Tarim Basin mummies
2021 · Nature · 181 citations
https://doi.org/10.1038/s41586-021-04052-7
Macrophage miR-34a Is a Key Regulator of Cholesterol Efflux and Atherosclerosis
2019 · Molecular Therapy · 121 citations
https://doi.org/10.1016/j.ymthe.2019.09.008
Enrichment of NPC1-deficient cells with the lipid LBPA stimulates autophagy, improves lysosomal function, and reduces cholesterol storage
2021 · Journal of Biological Chemistry · 50 citations
https://doi.org/10.1016/j.jbc.2021.100813
The Basis for Acyl Specificity in the Tafazzin Reaction
2017 · Journal of Biological Chemistry · 45 citations
https://doi.org/10.1074/jbc.m116.769182
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat